ArticleJournal of women's health (2002)2008
Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland clinic prevention database study.
Article in Journal of women's health (2002), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis.Journal of the American Heart Association · 2020Pooled it
- Combined Brain-Cardiac CT in Ischemic Stroke: Unveiling Atrial Markers Linked to Large Vessel Occlusion in AF Patients.European journal of neurology · 2025Article
- Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration.BMJ open diabetes research & care · 2024Article
- Sex Disparities in the Management of Acute Coronary Syndromes: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.Journal of the American Heart Association · 2024Article
- Statin therapy impact on Long-Term outcomes in acute heart Failure: Retrospective analysis of hospitalized patients.International journal of cardiology. Heart & vasculature · 2024Article
- Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study.Anatolian journal of cardiology · 2024Observational
- Differences in primary and secondary stroke prevention strategies for Chinese men and women.Preventive medicine reports · 2023Article
- Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists.American journal of preventive cardiology · 2023Review
- Underutilization of Statin Therapy for Secondary Prevention of Cardiovascular Disease Among Older Adults.Population health management · 2019Article
- Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.BMC cardiovascular disorders · 2018Article
- Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.Journal of women's health (2002) · 2018Article
- Women and Ischemic Heart Disease: Recognition, Diagnosis and Management.Korean circulation journal · 2016Review
- Article
- Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden.BMJ open · 2013Article
- Understanding gender differences in statin use among elderly Medicare beneficiaries: an application of decomposition technique.Drugs & aging · 2012Article
- A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.BMC cardiovascular disorders · 2011Article
- Gender and microvascular angina.Journal of thrombosis and thrombolysis · 2011Review
- Protective vascular treatment of patients with peripheral arterial disease: guideline adherence according to year, age and gender.Canadian journal of public health = Revue canadienne de sante publiqueArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPrevious studies have suggested that women with cardiovascular disease may receive less aggressive care than men. Using a large cardiology database from a tertiary referral center, we sought to determine if treatment differences still persist in the current era.
methodsWe analyzed data on 2462 patients who were referred for secondary prevention to the Preventive Cardiology Clinic at The Cleveland Clinic Foundation between 1997 and 2004. The primary objective was to evaluate use of effective secondary preventive therapies, by gender, as outlined in the ACC/AHA guidelines, such as antiplatelet therapy, beta-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors. Multivariate logistic regression analysis was performed to assess the independent effect of gender on all cause mortality.
resultsWomen were older (62.2 +/- 11.1 vs. 59.4 +/- 11.0, p < 0.001) and more likely to be hypertensive (68.1% vs. 56.1%, p < 0.001) than men. Overall, women were more likely than men to have higher baseline C-reactive protein (CRP) (6.14 +/- 13.4 vs. 4.9 +/- 10.7, p < 0.001), low-density lipoprotein cholesterol (LDL-C) (135 +/- 66 vs. 116 +/- 46, p < 0.001), high-density lipoprotein cholesterol (HDL-C) (52 +/- 17 vs. 41 +/- 11, p < 0.001), and total cholesterol (238 +/- 98 vs. 202 +/- 65, p < 0.001). Women were less likely to be on antiplatelet therapy (76.6 % vs. 85.0%, p < 0.001) and statins or any lipid-lowering therapy (62.6% vs. 67.1%, p = 0.04) compared with men on presentation.
conclusionsEven in the current era, women with established cardiovascular disease continue to receive less aggressive care than men. They are less likely to be on aspirin and statin therapy. More aggressive efforts should be made to treat both men and women with standard secondary preventive efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.